Fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) are inhibited in hyperoxia, leading to bronchopulmonary dysplasia in humans, demonstrating a linkage between ROS, growth factors and lung development [75]. The gene discussed is VEGFA; the disease is bronchopulmonary dysplasia.